HomeVIRP • EPA
Virbac SA
€392.00
Sep 27, 6:00:00 PM GMT+2 · EUR · EPA · Disclaimer
StockFR listed securityFR headquartered
Previous close
€390.50
Day range
€386.50 - €393.00
Year range
€242.00 - €400.00
Market cap
3.23B EUR
Avg Volume
3.08K
P/E ratio
23.36
Dividend yield
0.34%
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
351.47M15.15%
Operating expense
166.89M13.08%
Net income
47.33M26.16%
Net profit margin
13.479.60%
Earnings per share
EBITDA
84.35M33.61%
Effective tax rate
33.28%
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
158.64M-29.27%
Total assets
1.80B26.44%
Total liabilities
801.99M53.43%
Total equity
994.24M
Shares outstanding
8.37M
Price to book
3.29
Return on assets
10.37%
Return on capital
13.30%
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
47.33M26.16%
Cash from operations
18.30M121.37%
Cash from investing
-183.62M-1,040.48%
Cash from financing
127.14M546.08%
Net change in cash
-38.19M-422.43%
Free cash flow
44.04M32.67%
About
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick. The company is the 6th the largest veterinarian pharmaceutical group with a turnover of 1,247 million euros in 2023. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME. Wikipedia
Founded
1968
Employees
5,459
Search
Clear search
Close search
Google apps
Main menu